Comparing different adjuvants for peanut allergy treatment
Adjuvant Comparison and Characterization of Peanut Antigen
This study is looking at how different ingredients can make peanut allergy vaccines work better, and it's for anyone interested in improving treatments for peanut allergies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11121706 on NIH RePORTER |
What this research studies
This research investigates how various adjuvants can enhance the effectiveness of vaccines aimed at treating peanut allergies. By comparing these adjuvants alongside relevant vaccine platforms, the study aims to create detailed immunological profiles that reveal how different adjuvants work in the body. The research involves collaboration among multiple contractors who will share their findings to improve vaccine development. Ultimately, the goal is to develop more effective vaccines for allergic and autoimmune diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with peanut allergies or those at risk of developing them.
Not a fit: Patients without peanut allergies or those who do not have a history of allergic reactions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines for peanut allergies and potentially other allergic conditions.
How similar studies have performed: Previous research has shown promise in using adjuvants to enhance vaccine efficacy, indicating that this approach could lead to significant advancements in allergy treatment.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Staats, Herman — Duke University
- Study coordinator: Staats, Herman
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.